Cumberland Pharmaceuticals CPIX Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's operating lease liabilities?
- Cumberland Pharmaceuticals (CPIX) reported operating lease liabilities of $4.34M in Q1 2026.
- How has Cumberland Pharmaceuticals's operating lease liabilities changed year-over-year?
- Cumberland Pharmaceuticals's operating lease liabilities decreased by 10.0% year-over-year, from $4.83M to $4.34M.
- What is the long-term trend for Cumberland Pharmaceuticals's operating lease liabilities?
- Over 5 years (2020 to 2025), Cumberland Pharmaceuticals's operating lease liabilities has grown at a 33.4% compound annual growth rate (CAGR), from $1.06M to $4.47M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.